WA
APTO

WealthTrust Axiom’s Aptose Biosciences, Inc. APTO Stock Holding History

WealthTrust Axiom’s Portfolio APTO Stock Details APTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-33
Closed -$9.6K – 262
2023
Q1 		$9.6K Hold
33
– – ﹤0.01% 248
2022
Q4 		$8.7K Hold
33
– – ﹤0.01% 243
2022
Q3 		$8K Hold
33
– – ﹤0.01% 241
2022
Q2 		$11K Hold
33
– – ﹤0.01% 244
2022
Q1 		$20K Hold
33
– – 0.01% 261
2021
Q4 		$20K Hold
33
– – 0.01% 262
2021
Q3 		$32K Hold
33
– – 0.01% 250
2021
Q2 		$49K Buy
+33
New +$71.9K 0.02% 261

Other funds holding APTO

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
AC
Annandale Capital Dallas, Texas $709M AUM 11.03% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

WealthTrust Axiom's APTO Position: Q2 2023 in Review

WealthTrust Axiom sold out of Aptose Biosciences, Inc. (APTO) in Q2 2023, closing a stake of 33 shares — an estimated $9.6K sold.

WealthTrust Axiom first reported a position in APTO in Q2 2021 and held it in 8 quarters. The position peaked at $49K in Q2 2021. 24 funds tracked by Wall St. Rank hold APTO as of Q2 2023.

  • WealthTrust Axiom reported no remaining Aptose Biosciences, Inc. position as of Q2 2023 after selling out during the quarter.
  • WealthTrust Axiom sold 33 Aptose Biosciences, Inc. shares in Q2 2023, an estimated $9.6K.
  • WealthTrust Axiom first reported a position in Aptose Biosciences, Inc. in Q2 2021 and held it in 8 quarters.
  • WealthTrust Axiom's Aptose Biosciences, Inc. position peaked at $49K in Q2 2021.
  • 24 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q2 2023.

Based on WealthTrust Axiom's 13F filing for Q2 2023, filed 4 Aug 2023.